Literature DB >> 23906663

Cannabis abuse is associated with better emotional memory in schizophrenia: a functional magnetic resonance imaging study.

Josiane Bourque1, Adrianna Mendrek, Myriam Durand, Nadia Lakis, Olivier Lipp, Emmanuel Stip, Pierre Lalonde, Sylvain Grignon, Stéphane Potvin.   

Abstract

In schizophrenia cannabis abuse/dependence is associated with poor compliance and psychotic relapse. Despite this, the reasons for cannabis abuse remain elusive, but emotions may play a critical role in this comorbidity. Accordingly, we performed a functional magnetic resonance imaging study of emotional memory in schizophrenia patients with cannabis abuse (dual-diagnosis, DD). Participants comprised 14 DD patients, 14 non-abusing schizophrenia patients (SCZ), and 21 healthy controls (HC) who had to recognize positive and negative pictures while being scanned. Recognition of positive and negative emotions was prominently impaired in SCZ patients, relative to HC, while differences between DD and HC were smaller. For positive and negative stimuli, we observed significant activations in frontal, limbic, temporal and occipital regions in HC; in frontal, limbic and temporal regions in DD; and in temporal, parietal, limbic and occipital regions in the SCZ group. Our results suggest that emotional memory and prefrontal lobe functioning are preserved in DD relative to SCZ patients. These results are consistent with previous findings showing that cannabis abuse is associated with fewer negative symptoms and better cognitive functioning in schizophrenia. Longitudinal studies will need to determine whether the relative preservation of emotional memory is primary or secondary to cannabis abuse in schizophrenia.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cannabis; Emotional memory; Functional imaging; Schizophrenia

Mesh:

Year:  2013        PMID: 23906663     DOI: 10.1016/j.pscychresns.2013.05.012

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  7 in total

Review 1.  Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives.

Authors:  Alison C Burggren; Anaheed Shirazi; Nathaniel Ginder; Edythe D London
Journal:  Am J Drug Alcohol Abuse       Date:  2019-07-31       Impact factor: 3.829

Review 2.  Neuroimaging Studies in Patients With Mental Disorder and Co-occurring Substance Use Disorder: Summary of Findings.

Authors:  Kaloyan Rumenov Stoychev
Journal:  Front Psychiatry       Date:  2019-10-23       Impact factor: 4.157

Review 3.  New Clinically Relevant Findings about Violence by People with Schizophrenia.

Authors:  Sheilagh Hodgins; Sanja Klein
Journal:  Can J Psychiatry       Date:  2016-07-11       Impact factor: 4.356

4.  The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability.

Authors:  Else-Marie Løberg; Siri Helle; Merethe Nygård; Jan Øystein Berle; Rune A Kroken; Erik Johnsen
Journal:  Front Psychiatry       Date:  2014-11-18       Impact factor: 4.157

5.  Patients with schizophrenia show aberrant patterns of basal ganglia activation: Evidence from ALE meta-analysis.

Authors:  Jessica A Bernard; Courtney E Russell; Raeana E Newberry; James R M Goen; Vijay A Mittal
Journal:  Neuroimage Clin       Date:  2017-02-11       Impact factor: 4.881

6.  Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders.

Authors:  Musa Basseer Sami; Sagnik Bhattacharyya
Journal:  J Psychopharmacol       Date:  2018-03-29       Impact factor: 4.153

7.  Interaction of schizophrenia and chronic cannabis use on reward anticipation sensitivity.

Authors:  Simon Fish; Foteini Christidi; Efstratios Karavasilis; Georgios Velonakis; Nikolaos Kelekis; Christoph Klein; Nicholas C Stefanis; Nikolaos Smyrnis
Journal:  NPJ Schizophr       Date:  2021-06-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.